Since 2021, Phenix has been responsible for revaluing unsold cosmetic products from the pharmaceutical group Pierre Fabre. Francis Lemontey, CSR Manager at Pierre Fabre, looks back on this collaboration.
Since 2021, before the French AGEC law came into effect in January 2022, the dermo-pharmaceutical group Pierre Fabre (2024 revenue: €3.1 billion, up by 9.5% at constant exchange rates) has entrusted Phenix with the revaluation of part of unsold cosmetics.
Do you have information to share with us?